Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FQ82V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,257
Award facts
- Contract value 100% obligated
- $10,256.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,256.76 by the Defense Logistics Agency on October 31, 2025, for the supply of Dupixent 300 mg/2 mL pens. This firm fixed-price delivery order is scheduled for completion by November 3, 2025, and represents a direct procurement through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements.
Dupixent (dupilumab) is a biologic medication used to treat various allergic and inflammatory conditions, including atopic dermatitis, asthma, and chronic rhinosinusitis. This delivery order supports the Defense Health Agency's medical supply requirements across military healthcare systems. AmerisourceBergen's role as a prime vendor through the DLA Troop Support Medical contract enables the company to provide comprehensive pharmaceutical and medical supply support to federal healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard, with flexibility to fulfill diverse therapeutic needs across the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB26FQ82V?
SPE2DB26FQ82V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FQ82V worth?
The government has obligated $10,257 on SPE2DB26FQ82V.
Is contract SPE2DB26FQ82V an order under another contract?
Yes. SPE2DB26FQ82V is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ82V competed?
The extent of competition for SPE2DB26FQ82V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award